https://scholarshare.temple.edu/entities/publication/fe0e16c8-c1a7-4ff9-bdc8-eeba603fd72c
Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53...
Non-small cell lung cancer (NSCLC) is the leading cause of cancer death worldwide, with a 5-year survival of only ~16%. Potential strategies to address NSCLC...
https://cir.nii.ac.jp/crid/1010000781815059968?lang=ja
Gefinitib("Iressa",ZD1839)inhibits SN38-triggered EFD sifnals and IL-8 production in gastric cancer...